Page 6 - Alkermes News Today

China Universal Asset Management Co. Ltd. raised its stake in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 352.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,306 shares of the company’s stock after buying an additional […]

Alkermes plc (NASDAQ:ALKS – Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 14,080,000 shares, an increase of 8.1% from the February 29th total of 13,020,000 shares. Based on an average trading volume of 1,840,000 shares, the […]

McGlone Suttner Wealth Management Inc. bought a new position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,073 shares of the company’s stock, valued at approximately $30,000. A number of other institutional investors also […]

Lead product candidate, nemvaleukin, is being developed to treat a wide range of solid tumors and is currently in two potentially registrational c...

Strategic shift prioritizes the development of GLP-1 implants for the treatment of obesity and chronic weight management Positive NPM-115 preclinical weight loss data comparable to semaglutide,...

These therapies can improve treatment adherence for patients, especially for those with a history of poor or uncertain adherence.

California State Teachers Retirement System lessened its stake in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 8.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 168,825 shares of the company’s stock after selling 16,559 shares during the quarter. California State Teachers […]

Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The

Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrade for Coty, downgrades for Alkermes, and…

UBS Group lowered shares of Alkermes (NASDAQ:ALKS – Free Report) from a neutral rating to a sell rating in a research report released on Tuesday, Marketbeat Ratings reports. The brokerage currently has $25.00 price objective on the stock. Several other analysts have also recently weighed in on the stock. Mizuho decreased their price objective on […]